Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions
The emergence and spread of drug-resistant pathogens, and our inability to develop new antimicrobials to combat resistance, have inspired scientists to seek out new targets for drug development. The Mycobacterium tuberculosis complex is a group of obligately aerobic bacteria that have specialized fo...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/88834 http://hdl.handle.net/10220/45962 |
| _version_ | 1826117190663798784 |
|---|---|
| author | Cook, Gregory M. Hards, Kiel Dunn, Elyse Heikal, Adam Nakatani, Yoshio Greening, Chris Crick, Dean C. Fontes, Fabio L. Pethe, Kevin Hasenoehrl, Erik Berney, Michael |
| author2 | Lee Kong Chian School of Medicine (LKCMedicine) |
| author_facet | Lee Kong Chian School of Medicine (LKCMedicine) Cook, Gregory M. Hards, Kiel Dunn, Elyse Heikal, Adam Nakatani, Yoshio Greening, Chris Crick, Dean C. Fontes, Fabio L. Pethe, Kevin Hasenoehrl, Erik Berney, Michael |
| author_sort | Cook, Gregory M. |
| collection | NTU |
| description | The emergence and spread of drug-resistant pathogens, and our inability to develop new antimicrobials to combat resistance, have inspired scientists to seek out new targets for drug development. The Mycobacterium tuberculosis complex is a group of obligately aerobic bacteria that have specialized for inhabiting a wide range of intracellular and extracellular environments. Two fundamental features in this adaptation are the flexible utilization of energy sources and continued metabolism in the absence of growth. M. tuberculosis is an obligately aerobic heterotroph that depends on oxidative phosphorylation for growth and survival. However, several studies are redefining the metabolic breadth of the genus. Alternative electron donors and acceptors may provide the maintenance energy for the pathogen to maintain viability in hypoxic, nonreplicating states relevant to latent infection. This hidden metabolic flexibility may ultimately decrease the efficacy of drugs targeted against primary dehydrogenases and terminal oxidases. However, it may also open up opportunities to develop novel antimycobacterials targeting persister cells. In this review, we discuss the progress in understanding the role of energetic targets in mycobacterial physiology and pathogenesis and the opportunities for drug discovery. |
| first_indexed | 2024-10-01T04:23:34Z |
| format | Journal Article |
| id | ntu-10356/88834 |
| institution | Nanyang Technological University |
| language | English |
| last_indexed | 2024-10-01T04:23:34Z |
| publishDate | 2018 |
| record_format | dspace |
| spelling | ntu-10356/888342020-11-01T05:17:17Z Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions Cook, Gregory M. Hards, Kiel Dunn, Elyse Heikal, Adam Nakatani, Yoshio Greening, Chris Crick, Dean C. Fontes, Fabio L. Pethe, Kevin Hasenoehrl, Erik Berney, Michael Lee Kong Chian School of Medicine (LKCMedicine) Oxidoreductase Tuberculostatic Agent DRNTU::Science::Medicine The emergence and spread of drug-resistant pathogens, and our inability to develop new antimicrobials to combat resistance, have inspired scientists to seek out new targets for drug development. The Mycobacterium tuberculosis complex is a group of obligately aerobic bacteria that have specialized for inhabiting a wide range of intracellular and extracellular environments. Two fundamental features in this adaptation are the flexible utilization of energy sources and continued metabolism in the absence of growth. M. tuberculosis is an obligately aerobic heterotroph that depends on oxidative phosphorylation for growth and survival. However, several studies are redefining the metabolic breadth of the genus. Alternative electron donors and acceptors may provide the maintenance energy for the pathogen to maintain viability in hypoxic, nonreplicating states relevant to latent infection. This hidden metabolic flexibility may ultimately decrease the efficacy of drugs targeted against primary dehydrogenases and terminal oxidases. However, it may also open up opportunities to develop novel antimycobacterials targeting persister cells. In this review, we discuss the progress in understanding the role of energetic targets in mycobacterial physiology and pathogenesis and the opportunities for drug discovery. Published version 2018-09-12T06:14:11Z 2019-12-06T17:11:52Z 2018-09-12T06:14:11Z 2019-12-06T17:11:52Z 2017 Journal Article Cook, G. M., Hards, K., Dunn, E., Heikal, A., Nakatani, Y., Greening, C., . . . Berney, M. (2017). Oxidative Phosphorylation as a Target Space for Tuberculosis: Success, Caution, and Future Directions. Microbiology Spectrum, 5(3). doi:10.1128/microbiolspec.TBTB2-0014-2016 https://hdl.handle.net/10356/88834 http://hdl.handle.net/10220/45962 10.1128/microbiolspec.TBTB2-0014-2016 en Microbiology Spectrum © 2017 American Society for Microbiology. This paper was published in Microbiology Spectrum and is made available as an electronic reprint (preprint) with permission of American Society for Microbiology. The published version is available at: [http://dx.doi.org/10.1128/microbiolspec.TBTB2-0014-2016]. One print or electronic copy may be made for personal use only. Systematic or multiple reproduction, distribution to multiple locations via electronic or other means, duplication of any material in this paper for a fee or for commercial purposes, or modification of the content of the paper is prohibited and is subject to penalties under law. 22 p. application/pdf |
| spellingShingle | Oxidoreductase Tuberculostatic Agent DRNTU::Science::Medicine Cook, Gregory M. Hards, Kiel Dunn, Elyse Heikal, Adam Nakatani, Yoshio Greening, Chris Crick, Dean C. Fontes, Fabio L. Pethe, Kevin Hasenoehrl, Erik Berney, Michael Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions |
| title | Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions |
| title_full | Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions |
| title_fullStr | Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions |
| title_full_unstemmed | Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions |
| title_short | Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions |
| title_sort | oxidative phosphorylation as a target space for tuberculosis success caution and future directions |
| topic | Oxidoreductase Tuberculostatic Agent DRNTU::Science::Medicine |
| url | https://hdl.handle.net/10356/88834 http://hdl.handle.net/10220/45962 |
| work_keys_str_mv | AT cookgregorym oxidativephosphorylationasatargetspacefortuberculosissuccesscautionandfuturedirections AT hardskiel oxidativephosphorylationasatargetspacefortuberculosissuccesscautionandfuturedirections AT dunnelyse oxidativephosphorylationasatargetspacefortuberculosissuccesscautionandfuturedirections AT heikaladam oxidativephosphorylationasatargetspacefortuberculosissuccesscautionandfuturedirections AT nakataniyoshio oxidativephosphorylationasatargetspacefortuberculosissuccesscautionandfuturedirections AT greeningchris oxidativephosphorylationasatargetspacefortuberculosissuccesscautionandfuturedirections AT crickdeanc oxidativephosphorylationasatargetspacefortuberculosissuccesscautionandfuturedirections AT fontesfabiol oxidativephosphorylationasatargetspacefortuberculosissuccesscautionandfuturedirections AT pethekevin oxidativephosphorylationasatargetspacefortuberculosissuccesscautionandfuturedirections AT hasenoehrlerik oxidativephosphorylationasatargetspacefortuberculosissuccesscautionandfuturedirections AT berneymichael oxidativephosphorylationasatargetspacefortuberculosissuccesscautionandfuturedirections |